Page 1 | Search Results | Blood | American Society of Hematology

1-20 of 76

Sort by

Sort Order Select

Journal Articles

Multi-Drug Resistant Organisms Are Common in Fecal Surveillance Cultures and Do Not Predict Bacteremia but Correlate with Poorer Outcomes in Patients Undergoing Allogeneic Stem Cell Transplants

Vikram Mathews, MD DM, Alok Srivastava, Biju George, MD DM, Anu Korula, MD DM, Susmitha Perumalla, MD, Fouzia Nambiathayil Abubacker, DM, Nisham P N, MD D.M, Anup Devasia, MD D.M, Aby Abraham, MD DM, Veeraraghavan Balaji, MD, Kavitha M Lakshmi, MSc

Blood (2016) 128 (22): 3406.

https://doi.org/10.1182/blood.V128.22.3406.3406

Published: 2016

Journal Articles

Fate of Ikaros in Multiple Myeloma Cells upon Treatment with Lenalidomide and Proteasome Inhibitor

Saravanan Ganesan, MSc, Nithya Balasundaram, MSc, Hamenth Kumar Palani, MSc, Ansu Abu Alex, MSc, Sachin David, MSc, Anup Joseph Devasia, MD DM, Biju George, MD DM, Poonkuzhali Balasubramanian, MSc PhD, Vikram Mathews, MD DM

Blood (2016) 128 (22): 3281.

https://doi.org/10.1182/blood.V128.22.3281.3281

Published: 2016

Journal Articles

Metabolic Rewiring Drives Resistance to Arsenic Trioxide in Acute Promyelocytic Leukemia

Nithya Balasundaram, MSc, Saravanan Ganesan, MSc, Hamenth Kumar Palani, MSc, Ansu Abu Alex, MSc, Sachin David, MSc, Anu Korula, MD DM, Biju George, MD DM, Christine Chomienne, MD PhD, Poonkuzhali Balasubramanian, MSc PhD, Vikram Mathews, MD DM

Blood (2016) 128 (22): 3956.

https://doi.org/10.1182/blood.V128.22.3956.3956

Published: 2016

Journal Articles

Role of Pre-Transplant Cardiac and Hepatic T2* Magnetic Resonance for Risk Assessment in Patients with Thalassemia Major Undergoing an Allogeneic Stem Cell Transplantation

Vikram Mathews, MD DM, Alfred Inbaraj, MD, Anu Korula, MD DM, Nisham PN, MD DM, Fouzia NA, Dip NB, DM,, Anup Joseph Devasia, MD DM, Kavitha M Lakshmi, MSc, Aby Abraham, MD DM, Aparna Irodi, MD, Biju George, MD DM, Elizabeth Joseph, DMRD, DNB, Alok Srivastava

Blood (2016) 128 (22): 2200.

https://doi.org/10.1182/blood.V128.22.2200.2200

Published: 2016

Journal Articles

Second Hematopoietic SCT for Thalassemia Major: Improved Clinical Outcomes with a Treosulfan Based Conditioning Regimen

Vikram Mathews, MD DM, Anu Korula, MD DM, Nisham PN, MD DM, Anup Joseph Devasia, MD DM, Fouzia NA, Dip NB, DM,, Kavitha M Lakshmi, MSc, Aby Abraham, MD DM, Biju George, MD DM, Alok Srivastava

Blood (2016) 128 (22): 2201.

https://doi.org/10.1182/blood.V128.22.2201.2201

Published: 2016

Journal Articles

Alteration of the Hematopoietic Components, Mesenchymal Stromal Cells and Vascular Elements in the Bone Marrow Niche in Myelodysplastic Syndrome: Refractory Cytopenia with Multilineage Dysplasia

Salar Abbas, M.Sc, Aparna Venkatraman, PhD, Sanjay Kumar, PhD, Archana Kini, M.Sc, Marie Therese Manipadam, MD, Vivi M Srivastava, MD, Eunice Sindhuvi, PhD, Vikram Mathews, MD DM, Biju George, MD DM, Alok Srivastava

Blood (2016) 128 (22): 5516.

https://doi.org/10.1182/blood.V128.22.5516.5516

Published: 2016

Journal Articles

Osteoblast Differentiation of Stromal Cells Induced By Leukemic Cells

Saravanan Ganesan, MSc, Hamenth Kumar Palani, MSc, Vairavan Lakshmanan, B.Tech, Nithya Balasundaram, MSc, Ansu Abu Alex, MSc, Sachin David, MSc, Biju George, MD DM, Poonkuzhali Balasubramanian, MSc PhD, Neha Vyas, PhD, Dasaradhi Palakodeti, PhD, Vikram Mathews, MD DM

Blood (2016) 128 (22): 5062.

https://doi.org/10.1182/blood.V128.22.5062.5062

Published: 2016

Journal Articles

Role of miRNA in Micro-Environment Mediated Drug Resistance in Acute Promyelocytic Leukemia to Arsenic Trioxide

Saravanan Ganesan, MSc, Vairavan Lakshmanan, B.Tech, Hamenth Kumar Palani, MSc, Nithya Balasundaram, MSc, Ansu Abu Alex, MSc, Sachin David, MSc, Anu Korula, MD DM, Biju George, MD DM, Poonkuzhali Balasubramanian, MSc PhD, Harsha Gowda, PhD, Neha Vyas, PhD, Dasaradhi Palakodeti, PhD, Vikram Mathews, MD DM

Blood (2016) 128 (22): 5125.

https://doi.org/10.1182/blood.V128.22.5125.5125

Published: 2016

Journal Articles

Management of Relapsed Acute Promyelocytic Leukemia Post ATO Upfront Therapy: Open-Labeled Phase II Study Evaluating Role of Proteasome Inhibition

Vikram Mathews, MD DM, Anu Korula, MD DM, Uday Kulkarni, MD, Saravanan Ganesan, MSc, Sachin David, MSc, Ansu Abu Alex, MSc, Nisham PN, MD DM, Aby Abraham, MD DM, Alok Srivastava, Kavitha M Lakshmi, MSc, Poonkuzhali Balasubramanian, MSc PhD, Biju George, MD DM

Blood (2016) 128 (22): 446.

https://doi.org/10.1182/blood.V128.22.446.446

Published: 2016

Journal Articles

A 5'UTR Polymorphism in NT5E Gene Influences Outcome in Patients with Acute Myeloid Leukemia Undergoing Hematopoietic Stem Cell Transplantation with Fludarabine Based Conditioning Regimen

Ezhilpavai Mohanan, MSc, John C Panetta, PhD, Kavitha M Lakshmi, MSc, Anup Joseph Devasia, MD DM, Nisham PN, MD DM, Anu Korula, MD DM, Fouzia NA, Dip NB, DM,, Aby Abraham, MD DM, Biju George, MD DM, Alok Srivastava, Vikram Mathews, MD DM, Poonkuzhali Balasubramanian, MSc PhD

Blood (2016) 128 (22): 984.

https://doi.org/10.1182/blood.V128.22.984.984

Published: 2016

Journal Articles

Clinical and Molecular Characterization of Fanconi Anemia: An Indian Perspective

Nancy Beryl Janet Arthur, M.Sc, Abhijeet P Ganapule, MD, Dhavapriya Palani, B.Sc, Auro Viswabandya, MD, Vikram Mathews, MD, Aby Abraham, MD, Vivi M Srivastava, MD, Alok Srivastava, MD, Biju George, MD, Shaji R Velayudhan, PhD

Blood (2014) 124 (21): 2938.

https://doi.org/10.1182/blood.V124.21.2938.2938

Published: 2014

Journal Articles

Pharmacokinetics of Fludarabine in Patients with Aplastic Anemia Undergoing Hematopoietic Stem Cell Transplantation

Ezhil Pavai Mohanan, MSc, John C Panetta, PhD, Kavitha M Lakshmi, MSc, Fouzia NA, MD, Abhijeet Ganapule, MD, Aby Abraham, MD, Auro Viswabandya, MD, Alok Srivastava, MD, Vikram Mathews, MD, Biju George, MD, Poonkuzhali Balasubramanian, PhD

Blood (2014) 124 (21): 3884.

https://doi.org/10.1182/blood.V124.21.3884.3884

Published: 2014

Journal Articles

Population Pharmacokinetics of Daunorubicin in AML: Influence on Clinical Outcome

Savitha Varatharajan, M.Sc, Ajay Abraham, M.Sc, John C Panetta, PhD, Sreeja Karathedath, M.Sc, Kavitha M Lakshmi, MSc, Chepsy C Philip, MD, Fouzia NA, MD, Abhijeet Ganapule, MD, Aby Abraham, MD, Auro Viswabandya, MD, Biju George, MD, Alok Srivastava, MD, Vikram Mathews, MD, Poonkuzhali Balasubramanian, PhD

Blood (2014) 124 (21): 902.

https://doi.org/10.1182/blood.V124.21.902.902

Published: 2014

Journal Articles

The Addition of Meloxicam to G-CSF Is Associated with Good Mobilization Rates, Faster Engraftment and Reduced Toxicity and Hospital Stay after Autologous Stem Cell Transplantation – a Phase II Study

Biju George, MD, Auro Viswabandya, MD, Ansu Abu Alex, MSc,, Kavitha M Lakshmi, MSc, Aby Abraham, MD, Abhijeet Ganapule, MD, Fouzia N, Alok Srivastava, MD, Vikram Mathews, MD

Blood (2014) 124 (21): 2455.

https://doi.org/10.1182/blood.V124.21.2455.2455

Published: 2014

Journal Articles

Pre-Transplant Consolidation and Cost Effectiveness of RIC Allogeneic SCT in Patients of AML-CR1 in India

Blood (2014) 124 (21): 2462.

https://doi.org/10.1182/blood.V124.21.2462.2462

Published: 2014

Journal Articles

Proteasome Activity Is Dispensable for the Degradation of PML-RARα: Efficacy of Bortezomib Along with Arsenic Trioxide in the Treatment of Arsenic Sensitive and Resistant Acute Promyelocytic Leukemia

Saravanan Ganesan, MSc, Ansu Abu Alex, MSc, Ezhilarasi Chendamarai, PhD, Nithya Balasundaram, MSc, Hamenth Kumar Palani, MSc, Sachin David, MSc, Jayandharan G Rao, PhD, Aby Abraham, MD, Auro Viswabandya, MD, Biju George, MD, Alok Srivastava, MD, Poonkuzhali Balasubramanian, PhD, Rose Ann Padua, PhD, Christine Chomienne, MD PhD, Vikram Mathews, MD

Blood (2014) 124 (21): 3741.

https://doi.org/10.1182/blood.V124.21.3741.3741

Published: 2014

Journal Articles

Clinical Profile and Outcome Of Patients With Graft Rejection Following Related HLA Matched Allogeneic Stem Cell Transplant For β Thalassemia Major

Vikram Mathews, MD, Abhijeet Ganapule, MD, Biju George, MD, Kavitha M Lakshmi, MSc, Aby Abraham, MD, Auro Viswabandya, MD, Alok Srivastava, MD

Blood (2013) 122 (21): 4546.

https://doi.org/10.1182/blood.V122.21.4546.4546

Published: 2013

Journal Articles

Role Of Stress Responsive Genes Responsible In Molecular Switch From Adaptive Phase To Apoptosis In HbE−β Thalassemia

Divya Jayasree, MSc, Ramachandran V Shaji, Biju George, MD, Alok Srivastava, MD, Vikram Mathews, MD, Eunice Sindhuvi Edison, Ph.D

Blood (2013) 122 (21): 3447.

https://doi.org/10.1182/blood.V122.21.3447.3447

Published: 2013

Journal Articles

Pharmacokinetics Of a Generic Formulation Of Intravenous Busulfan (BUCELON 60™) In Patients Undergoing Hematopoietic Stem Cell Transplantation

Ezhilpavai Mohanan, M.Sc, Salamun Desire, M.Sc, Sathya Mani, Gopinath Srinivasan, Biju George, MD, Vikram Mathews, MD, Alok Srivastava, MD, Poonkuzhali Balasubramanian, Ph.D

Blood (2013) 122 (21): 3280.

https://doi.org/10.1182/blood.V122.21.3280.3280

Published: 2013

Journal Articles

NK Cell Mediated Cytotoxicity Against Malignant Promyelocytes Enhanced By Arsenic Trioxide: Potential Clinical Relevance

Ansu Abu Alex, MSc, Hamenth Kumar P, MSc, Saravanan Ganesan, MSc, Nithya Balasundaram, MSc, Kavitha M Lakshmi, MSc, Biju George, MD, Aby Abraham, MD, Auro Viswabandya, MD, Alok Srivastava, MD, Rose Ann Padua, PhD, Christine Chomienne, MD, PhD, Poonkuzhali Balasubramanian, Ph.D, Vikram Mathews, MD

Blood (2013) 122 (21): 1455.

https://doi.org/10.1182/blood.V122.21.1455.1455

Published: 2013

NARROW

Multi-Drug Resistant Organisms Are Common in Fecal Surveillance Cultures and Do Not Predict Bacteremia but Correlate with Poorer Outcomes in Patients Undergoing Allogeneic Stem Cell Transplants

Fate of Ikaros in Multiple Myeloma Cells upon Treatment with Lenalidomide and Proteasome Inhibitor

Metabolic Rewiring Drives Resistance to Arsenic Trioxide in Acute Promyelocytic Leukemia

Role of Pre-Transplant Cardiac and Hepatic T2* Magnetic Resonance for Risk Assessment in Patients with Thalassemia Major Undergoing an Allogeneic Stem Cell Transplantation

Second Hematopoietic SCT for Thalassemia Major: Improved Clinical Outcomes with a Treosulfan Based Conditioning Regimen

Alteration of the Hematopoietic Components, Mesenchymal Stromal Cells and Vascular Elements in the Bone Marrow Niche in Myelodysplastic Syndrome: Refractory Cytopenia with Multilineage Dysplasia

Osteoblast Differentiation of Stromal Cells Induced By Leukemic Cells

Role of miRNA in Micro-Environment Mediated Drug Resistance in Acute Promyelocytic Leukemia to Arsenic Trioxide

Management of Relapsed Acute Promyelocytic Leukemia Post ATO Upfront Therapy: Open-Labeled Phase II Study Evaluating Role of Proteasome Inhibition

A 5'UTR Polymorphism in NT5E Gene Influences Outcome in Patients with Acute Myeloid Leukemia Undergoing Hematopoietic Stem Cell Transplantation with Fludarabine Based Conditioning Regimen

Clinical and Molecular Characterization of Fanconi Anemia: An Indian Perspective

Pharmacokinetics of Fludarabine in Patients with Aplastic Anemia Undergoing Hematopoietic Stem Cell Transplantation

Population Pharmacokinetics of Daunorubicin in AML: Influence on Clinical Outcome

The Addition of Meloxicam to G-CSF Is Associated with Good Mobilization Rates, Faster Engraftment and Reduced Toxicity and Hospital Stay after Autologous Stem Cell Transplantation – a Phase II Study

Pre-Transplant Consolidation and Cost Effectiveness of RIC Allogeneic SCT in Patients of AML-CR1 in India

Proteasome Activity Is Dispensable for the Degradation of PML-RARα: Efficacy of Bortezomib Along with Arsenic Trioxide in the Treatment of Arsenic Sensitive and Resistant Acute Promyelocytic Leukemia

Clinical Profile and Outcome Of Patients With Graft Rejection Following Related HLA Matched Allogeneic Stem Cell Transplant For β Thalassemia Major

Role Of Stress Responsive Genes Responsible In Molecular Switch From Adaptive Phase To Apoptosis In HbE−β Thalassemia

Pharmacokinetics Of a Generic Formulation Of Intravenous Busulfan (BUCELON 60™) In Patients Undergoing Hematopoietic Stem Cell Transplantation

NK Cell Mediated Cytotoxicity Against Malignant Promyelocytes Enhanced By Arsenic Trioxide: Potential Clinical Relevance

Email alerts

ASH Publications

American Society of Hematology

Email alerts

ASH Publications

American Society of Hematology

This Feature Is Available To Subscribers Only